Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-07-14

Clinical Trial Update: SRL (Sirolimus) Withdrawal [NA]

View source ↗

Summary

A completed clinical trial update on sirolimus withdrawal in the context of liver transplant acute rejection and immunosuppressant therapy effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirolimus (Sirolimus)

Snippet

Sponsor: Northwestern University | Conditions: Acute Rejection of Liver Transplant, Effects of Immunosuppressant Therapy | NA | Status: COMPLETED | Results posted: 2022-07-14